Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neurocrine Bioscienc (NQ: NBIX ) 147.77 +1.08 (+0.74%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Neurocrine Bioscienc < Previous 1 2 3 4 5 6 7 8 Next > Why Neurocrine Biosciences Shares Fell Nearly 10% Today November 02, 2021 Investors have grown weary of unpredictable profitability and unexpected expenses. Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's Intraday Session November 02, 2021 Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%... Via Benzinga What 5 Analyst Ratings Have To Say About Neurocrine Biosciences November 02, 2021 Over the past 3 months, 5 analysts have published their opinion on Neurocrine Biosciences (NASDAQ: Via Benzinga The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US November 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... Via Benzinga Exposures COVID-19 Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript November 01, 2021 NBIX earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Monday's After-Market Session November 01, 2021 Gainers Biophytis (NASDAQ:BPTS) shares mo... Via Benzinga Neurocrine Biosciences: Q3 Earnings Insights November 01, 2021 Neurocrine Biosciences (NASDAQ:NBIX) reported its Q3 earnings results on Monday, November 1, 2021 at 04:01 PM. Here's what investors need to know about the announcement.... Via Benzinga Neurocrine Biosciences's Return On Capital Employed Overview November 01, 2021 According to Benzinga Pro, during Q2, Neurocrine Biosciences (NASDAQ:NBIX) earned $62.80 million, a 99.37% increase from the preceding quarter. Neurocrine Biosciences also posted... Via Benzinga Looking into Neurocrine Biosciences's Return on Capital Employed August 20, 2021 After pulling data from Benzinga Pro it seems like during Q2, Neurocrine Biosciences (NASDAQ:NBIX) earned $62.80 million, a 99.37% increase from the preceding quarter. Neurocrine... Via Benzinga Earnings Scheduled For November 1, 2021 November 01, 2021 Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:... Via Benzinga The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 October 14, 2021 Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX: Via Benzinga Stocks That Hit 52-Week Lows On Wednesday August 11, 2021 On Wednesday morning, 67 companies achieved new lows for the year. Areas of Significance: Grifols (NASDAQ:GRFS) was the largest firm by market cap to set a new 52-... Via Benzinga The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO August 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering August 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021 August 06, 2021 Upgrades According to Wolfe Research, the prior rating for The AES Corp (NYSE: Via Benzinga Neurocrine Biosciences, inc (NBIX) Q2 2021 Earnings Call Transcript August 03, 2021 NBIX earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript May 06, 2021 NBIX earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Earnings Scheduled For August 3, 2021 August 03, 2021 Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to... Via Benzinga Parkinson’s Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027 May 05, 2021 Via FinancialNewsMedia Biotechs Aligning to Address Challenges for Developing Therapeutics for Billion Dollar Neurological Disorders Industry April 22, 2021 Via FinancialNewsMedia Exposures COVID-19 The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.